Paragon 28, Inc. (FNA)

Compare

13.05

-0.02

(-0.15%)

At close: April 4 at 4:00:02 PM EDT

13.05

0.00

(0.00%)

After hours: April 4 at 6:09:32 PM EDT

Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference

ENGLEWOOD, Colo., March 24, 2025--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference. From March 27-29, Paragon 28 will feature a suite of recently launched products designed to improve foot and ankle patient outcomes and surgeon experience.

Business Wire 13 days ago

FNA
-0.15%
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?

Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.

Zacks 17 days ago

FNA
-0.15%
AGL
Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act

ENGLEWOOD, Colo., March 11, 2025--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with the previously announced acquisition of Paragon 28 by Zimmer Biomet Holdings, Inc. (NYSE: ZBH) ("Zimmer Biomet").

Business Wire 26 days ago

FNA
-0.15%
Paragon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual Conference

ENGLEWOOD, Colo., March 07, 2025--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American Academy of Orthopaedic Surgeons ("AAOS").

Business Wire 29 days ago

FNA
-0.15%
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -33.33% and 10.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

FNA
-0.15%
Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 performance with nearly 5% constant currency revenue growth and outlines strategic plans for future innovation and market expansion.

GuruFocus.com last month

ZBH

FNA
-0.15%
Q4 2024 Zimmer Biomet Holdings Inc Earnings Call

Q4 2024 Zimmer Biomet Holdings Inc Earnings Call

Thomson Reuters StreetEvents last month

ZBH

FNA
-0.15%
Why Is Zimmer Biomet Stock Trading Lower On Thursday?

On Thursday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported sales of $2.02 billion, up 4.3% on a reported basis (+4.9% on constant currency), beating the consensus of $2.014 billion. Knee product sales increased 5.1% to $839.2 million, and hip product sales increased 3% (+4% on constant currency) to $520 million. Sports Medicine products generated sales of $489.4

Benzinga last month

ZBH

FNA
-0.15%
Zimmer touts ASC opportunity with Paragon 28 purchase

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.

MedTech Dive last month

ZBH

FNA
-0.15%
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2024. The Company reported fourth quarter net sales of $2.023 billion, an increase of 4.3% over the prior year period, and an increase of 4.9% on a constant currency1 basis. Net sales for the full year were $7.679 billion, an increase of 3.8% over the prior year, and an increase of 4.8% on a constant currency1 basis. Net earnings for the fourth quarter were $239.4 million

PR Newswire last month

FNA
-0.15%
ZBH
Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?

Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 2 months ago

FNA
-0.15%
TMDX
Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal

Acquisition expands Zimmer Biomet's presence in the $5 billion foot and ankle market.

GuruFocus.com 2 months ago

ZBH

FNA
-0.15%
Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn

The transaction is anticipated to close in the first half of this year.

Medical Device Network 2 months ago

FNA
-0.15%
ZBH
Zimmer to buy Paragon 28 for $1.1B

Needham analysts, who were surprised by the bargain for Paragon 28, said Zimmer may not be done spending.

MedTech Dive 2 months ago

ZBH

FNA
-0.15%
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details

Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be acquired by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) at around $1.1 billion in equity and $1.2 billion in enterprise value. Zimmer Biomet plans to purchase all common shares of Paragon 28 for for an upfront payment of $13.00 per share in cash. Also, Paragon 28 shareholders will receive a non-tradeable contingent value right (CVR) of up to $1.00 per share in cash, contingent on

Benzinga 2 months ago

FNA
-0.15%
ZBH
Zimmer Biomet to Acquire Paragon 28 for $1.1 Billion in Cash

Zimmer Biomet Holdings (ZBH) said Tuesday it plans to acquire all outstanding Paragon 28 (FNA) share

PREMIUM
MT Newswires 2 months ago

FNA
-0.15%
ZBH
Zimmer Biomet to buy Paragon 28 for $1.1 billion

The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments, while bolstering its fracture and trauma, and joint replacement businesses. Under the terms of the deal, Zimmer Biomet will make an upfront payment of $13.00 per share in cash, which represents an 8.3% premium to Paragon's closing price on Tuesday. Shares of Paragon 28 rose 9.3% in extended trading.

Reuters 2 months ago

ZBH

FNA
-0.15%
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of

PR Newswire 2 months ago

FNA
-0.15%
ZBH
Paragon 28 sees Q4 revenue $$71.5M-$71.8M , consensus $69.62M

Preliminary unaudited net revenue for the fourth quarter of 2024 is expected to be in a range of $71.5 to $71.8 million, representing reported growth of approximately 18.0% to 18.5% compared to the fourth quarter of 2023. Preliminary unaudited net revenue for the full year of 2024 is expected to be in a range of $255.9 Mto $256.2M, Consensus $254.05M…”2024 has been a transformative year for Paragon 28 (FNA), marked by significant achievements in growth, innovation, and operational efficiency. Ou

TipRanks 2 months ago

FNA
-0.15%
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024

ENGLEWOOD, Colo., January 13, 2025--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "P28"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2024.

Business Wire 2 months ago

FNA
-0.15%

Performance Overview

Return	FNA	S&P 500 (^GSPC)
YTD	+26.33%	-13.73%
1-Year	+27.94%	-1.42%
3-Year	-23.91%	+10.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Paragon 28, Inc. (FNA)

Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference

Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?

Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act

Paragon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual Conference

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates

Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Q4 2024 Zimmer Biomet Holdings Inc Earnings Call

Why Is Zimmer Biomet Stock Trading Lower On Thursday?

Zimmer touts ASC opportunity with Paragon 28 purchase

Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results

Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?

Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal

Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn

Zimmer to buy Paragon 28 for $1.1B

Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details

Zimmer Biomet to Acquire Paragon 28 for $1.1 Billion in Cash

Zimmer Biomet to buy Paragon 28 for $1.1 billion

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28

Paragon 28 sees Q4 revenue $$71.5M-$71.8M , consensus $69.62M

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024

Performance Overview